GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huaren Pharmaceutical Co Ltd (SZSE:300110) » Definitions » Market Cap

Huaren Pharmaceutical Co (SZSE:300110) Market Cap : ¥3,499 Mil (As of Apr. 16, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Huaren Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Huaren Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥3.65. Huaren Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 1,182 Mil. Therefore, Huaren Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥4,315 Mil.

Huaren Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥4,232 Mil) to Jun. 2024 (¥3,653 Mil) but then increased from Jun. 2024 (¥3,653 Mil) to Sep. 2024 (¥4,315 Mil).

Huaren Pharmaceutical Co's annual market cap declined from Dec. 2021 (¥5,675 Mil) to Dec. 2022 (¥5,013 Mil) and declined from Dec. 2022 (¥5,013 Mil) to Dec. 2023 (¥4,989 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Huaren Pharmaceutical Co's Enterprise Value for Today is ¥5,138 Mil.


Huaren Pharmaceutical Co Market Cap Historical Data

The historical data trend for Huaren Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huaren Pharmaceutical Co Market Cap Chart

Huaren Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,988.94 5,591.87 5,674.62 5,012.58 4,988.94

Huaren Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,929.83 4,988.94 4,232.32 3,653.04 4,315.08

Competitive Comparison of Huaren Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Huaren Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huaren Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huaren Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Huaren Pharmaceutical Co's Market Cap falls into.


;
;

Huaren Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Huaren Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥4.22*1182.213
=¥4,989

Huaren Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥3.65*1182.213
=¥4,315

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huaren Pharmaceutical Co  (SZSE:300110) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Huaren Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Huaren Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Huaren Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
Executives
Yang Xiao Dong Director
Bo Guo Xiu Executives
Zhou Xi Jian Director
Mao Yu Wei Supervisors
Chu Xiao Jun Executives
Zhou Qiang Directors, executives
Ji Sheng Bin Executives
Xiao Wei Wen Executives
Shen Hong Ce Executives
Li Xiao Li Executives
Liu Qian Executives
Wang Wen Ping Executives
Liang Fu You Director
Liang Fu Dong Director
Gong Ling Secretary Dong

Huaren Pharmaceutical Co Headlines

No Headlines